Tergooi Mc
Hilversum 1212VG
2 studies enrolling now · 2 studies all time
What they study most
Acute Myocardial Infarction, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Studies at this site
- A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL) — Recruiting now
- Selatogrel Outcome Study in Suspected Acute Myocardial Infarction — Enrolling by invitation